237 related articles for article (PubMed ID: 27171391)
1. Copeptin predicts 10-year all-cause mortality in community patients: a 10-year prospective cohort study.
Odermatt J; Bolliger R; Hersberger L; Ottiger M; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
Clin Chem Lab Med; 2016 Oct; 54(10):1681-90. PubMed ID: 27171391
[TBL] [Abstract][Full Text] [Related]
2. Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.
Odermatt J; Meili M; Hersberger L; Bolliger R; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
BMC Cardiovasc Disord; 2017 Jul; 17(1):178. PubMed ID: 28676115
[TBL] [Abstract][Full Text] [Related]
3. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
[TBL] [Abstract][Full Text] [Related]
4. The natriuretic peptide MR-proANP predicts all-cause mortality and adverse outcome in community patients: a 10-year follow-up study.
Odermatt J; Hersberger L; Bolliger R; Graedel L; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
Clin Chem Lab Med; 2017 Aug; 55(9):1407-1416. PubMed ID: 28107168
[TBL] [Abstract][Full Text] [Related]
5. Copeptin as a prognostic biomarker in acute myocardial infarction.
Lattuca B; Sy V; Nguyen LS; Bernard M; Zeitouni M; Overtchouk P; Yan Y; Hammoudi N; Ceccaldi A; Collet JP; Kerneis M; Diallo A; Montalescot G; Silvain J
Int J Cardiol; 2019 Jan; 274():337-341. PubMed ID: 30217427
[TBL] [Abstract][Full Text] [Related]
6. Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction.
Pozsonyi Z; Förhécz Z; Gombos T; Karádi I; Jánoskuti L; Prohászka Z
Heart Lung Circ; 2015 Apr; 24(4):359-67. PubMed ID: 25618448
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of copeptin: one-year outcome in patients with acute stroke.
Urwyler SA; Schuetz P; Fluri F; Morgenthaler NG; Zweifel C; Bergmann A; Bingisser R; Kappos L; Steck A; Engelter S; Müller B; Christ-Crain M; Katan M
Stroke; 2010 Jul; 41(7):1564-7. PubMed ID: 20508186
[TBL] [Abstract][Full Text] [Related]
8. Copeptin and risk stratification in patients with acute dyspnea.
Potocki M; Breidthardt T; Mueller A; Reichlin T; Socrates T; Arenja N; Reiter M; Morgenthaler NG; Bergmann A; Noveanu M; Buser PT; Mueller C
Crit Care; 2010; 14(6):R213. PubMed ID: 21106053
[TBL] [Abstract][Full Text] [Related]
9. Copeptin levels are associated with organ dysfunction and death in the intensive care unit after out-of-hospital cardiac arrest.
Ristagno G; Latini R; Plebani M; Zaninotto M; Vaahersalo J; Masson S; Tiainen M; Kurola J; Gaspari F; Milani V; Pettilä V; Skrifvars MB;
Crit Care; 2015 Mar; 19(1):132. PubMed ID: 25886856
[TBL] [Abstract][Full Text] [Related]
10. Copeptin Predicts Mortality in Critically Ill Patients.
Krychtiuk KA; Honeder MC; Lenz M; Maurer G; Wojta J; Heinz G; Huber K; Speidl WS
PLoS One; 2017; 12(1):e0170436. PubMed ID: 28118414
[TBL] [Abstract][Full Text] [Related]
11. Copeptin is an independent prognostic factor for transplant-free survival in cirrhosis.
Kerbert AJ; Weil D; Verspaget HW; Moréno JP; van Hoek B; Cervoni JP; Di Martino V; Coenraad MJ; Thevenot T
Liver Int; 2016 Apr; 36(4):530-7. PubMed ID: 26502363
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections.
Müller B; Morgenthaler N; Stolz D; Schuetz P; Müller C; Bingisser R; Bergmann A; Tamm M; Christ-Crain M
Eur J Clin Invest; 2007 Feb; 37(2):145-52. PubMed ID: 17217381
[TBL] [Abstract][Full Text] [Related]
13. Plasma copeptin and long-term outcomes in acute ischemic stroke.
Zhang JL; Yin CH; Zhang Y; Zhao LB; Fu HJ; Feng JC
Acta Neurol Scand; 2013 Dec; 128(6):372-80. PubMed ID: 23614762
[TBL] [Abstract][Full Text] [Related]
14. Plasma copeptin, a possible prognostic marker in cirrhosis.
Moreno JP; Grandclement E; Monnet E; Clerc B; Agin A; Cervoni JP; Richou C; Vanlemmens C; Dritsas S; Dumoulin G; Di Martino V; Thevenot T
Liver Int; 2013 Jul; 33(6):843-51. PubMed ID: 23560938
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction.
Potocki M; Reichlin T; Thalmann S; Zellweger C; Twerenbold R; Reiter M; Steuer S; Bassetti S; Drexler B; Stelzig C; Freese M; Winkler K; Haaf P; Balmelli C; Hochholzer W; Osswald S; Mueller C
Heart; 2012 Apr; 98(7):558-65. PubMed ID: 22337952
[TBL] [Abstract][Full Text] [Related]
16. Is copeptin level associated with 1-year mortality after out-of-hospital cardiac arrest? Insights from the Paris registry*.
Geri G; Dumas F; Chenevier-Gobeaux C; Bouglé A; Daviaud F; Morichau-Beauchant T; Jouven X; Mira JP; Pène F; Empana JP; Cariou A
Crit Care Med; 2015 Feb; 43(2):422-9. PubMed ID: 25599466
[TBL] [Abstract][Full Text] [Related]
17. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
[TBL] [Abstract][Full Text] [Related]
18. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
19. The utility of copeptin in the emergency department as a predictor of adverse outcomes in non-ST-elevation acute coronary syndrome: the COPED-PAO study.
Sánchez M; Llorens P; Herrero P; Martín-Sanchez FJ; Piñera P; Miró Ò;
Emerg Med J; 2014 Apr; 31(4):286-91. PubMed ID: 23371977
[TBL] [Abstract][Full Text] [Related]
20. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
